New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
February 1, 2023 - The FDA approved CMP Pharma’s Atorvaliq (atorvastatin) oral suspension.
Download PDF
Return to publications
